Results 1 to 10 of about 12,220,634 (288)

Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review). [PDF]

Exp Ther Med, 2021
Su H, Ma C, Li H.
europepmc   +1 more source

Discovery of Natural Phosphodiesterase 5 Inhibitors from <i>Dalbergia cochinchinensis</i> Pierre Leaves Using LC-QTOF-MS². [PDF]

Plants (Basel)
Chantakul R, Girard C, Senejoux F, Ingkaninan K, Nuengchamnong N, Temkitthawon P.   +5 more
europepmc   +1 more source

Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post- and Precapillary Pulmonary Hypertension: A Propensity Score-Matched Analysis From the Hellenic Pulmonary Hypertension Registry. [PDF]

Pulm Circ
Papadopoulos GE, Arvanitaki A, Mouratoglou SA, Gourgiotis P, Chrysochoidis-Trantas T, Mpatsouli A, Bechlioulis A, Naka A, Demerouti E, Karyofyllis P, Tsiapras D, Anthi A, Manginas A, Ziakas A, Rosenkranz S, Giannakoulas G.   +15 more
europepmc   +1 more source

Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US.

JAMA Ophthalmol, 2022
Etminan M, Sodhi M, Mikelberg FS, Maberley D.   +3 more
europepmc   +1 more source

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention

Aging, 2018
Islam, Bianca N., Browning, Darren D.
openaire   +2 more sources

Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis. [PDF]

Neurol Sci
Abouelmagd ME, Abdelmeseh M, Elrosasy A, Saad YH, Alnajjar AZ, Eid M, Hassan A, Abbas A.   +7 more
europepmc   +1 more source

Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease. [PDF]

Biochem Pharmacol, 2020
Zuccarello E, Acquarone E, Calcagno E, Argyrousi EK, Deng SX, Landry DW, Arancio O, Fiorito J.   +7 more
europepmc   +1 more source

Penile shear-wave elastography predicts the outcome of botulinum neurotoxin (Botox) in the management of non-responders to phosphodiesterase-5-inhibitors: A pilot study. [PDF]

Arab J Urol
Ragab MW, Shawky KA, Bendary AZEF, Albohy AM.   +3 more
europepmc   +1 more source

Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. [PDF]

Eur Heart J Cardiovasc Pharmacother
Soulaidopoulos S, Terentes-Printzios D, Ioakeimidis N, Tsioufis KP, Vlachopoulos C.   +4 more
europepmc   +1 more source

A Review of Combined Phosphodiesterase-5-Inhibitors and α-Blockers versus Phosphodiesterase-5-Inhibitors Alone for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia. [PDF]

Arab J Urol
Jackson EM, Khooblall P, Lundy SD, Bajic P.   +3 more
europepmc   +1 more source